FDA Advisory Committee Provides Opinion On Oritavancin For The Treatment Of Complicat

#1 (permalink)

11-20-2008, 07:16 PM

Reber

Senior Member

Join Date: Dec 2007

Posts: 281,701

FDA Advisory Committee Provides Opinion On Oritavancin For The Treatment Of Complicat

Targanta Therapeutics Corporation (Nasdaq: TARG) today announced that oritavancin, the Company's investigational antibiotic therapy for the treatment of complicated skin and skin structure infections (cSSSI) caused by gram-positive pathogens, including methicillin resistant Staphylococcus aureus (MRS

You must register in order to see the links

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Similar Threads
Thread	Thread Starter	Forum	Replies	Last Post
Society Has Integral Role On New Nice NHS Evidence Advisory Committee	Reber	General Health	0	11-19-2008 06:15 AM
Arpida Announces Review Of Iclaprim NDA By FDA Advisory Committee In November 2008	Reber	General Health	0	10-15-2008 03:12 PM
Strengthening the Advisory Committee Process	Reber	Food Recipes	0	08-05-2008 07:57 AM
FDA Advisory Committee Recommends Approval Of Actemra For The Treatment Of Rheumatoid	Reber	General Health	0	07-31-2008 02:03 PM
FDA Advisory Committee Provides Opinion Of DORIBAX(TM) For The Treatment Of Hospital	Reber	General Health	0	07-17-2008 10:23 PM

It is prohibited to publish illegal materials and content. Please inform us if you see such materials in our website via mail. We will concern with the matter as soon as possible.